Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Providers Use Therap's Disability Software to Generate Comprehensive Reports for Audits, Compliance and Quality Assurance

WATERBURY, Conn., Feb. 15, 2019 /PRNewswire/ -- Therap's electronic health record and documentation system is the leading software globally and within the United States to providers supporting individuals with intellectual and developmental disabilities. Its reporting features expand with regular... Read more ››

By: PR Newswire Association LLC. - 16 Feb 2019

Statement from ABC President John M. Fontaine, MD, on the 2018 ACC/AHA Guideline on Management of Blood Cholesterol

NEW YORK, Feb. 15, 2019 /PRNewswire/ -- The Association of Black Cardiologists, Inc. is a cosigner of the recently published Read more ››

By: PR Newswire Association LLC. - 16 Feb 2019

Acarix adapts pathway for German reimbursement - Submission of new dossier by the end of February 2019

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2019
Related companies:  Acarix AB

Merion, Inc. to Webcast Live at VirtualInvestorConferences.com February 20th

LOS ANGELES, Feb. 15, 2019 /PRNewswire/ -- Merion, Inc. (OTCQB: EWLU), based in Los Angeles, focused on high-tech small molecules +cell carrier nutrient products, today announced that David Li, Financial Adviser, will present live at VirtualInvestorConferences.com on February 20(th).... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019

Realm Therapeutics plc ("Realm Therapeutics", "Realm" or the "Company"), Update on Strategic Review, Proposed Assets Disposal, Proposed Adoption of Investing Policy, Proposed AIM Delisting and Notice of General Meeting

MALVERN, Pa., Feb. 15, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical company with a proprietary technology platform of stabilized high concentration HOCl, today provides an update on its previously announced strategic review.

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Realm Therapeutics, Inc.

ProfNet Experts Available on Emotional Health, Acupressure, More

NEW YORK, Feb. 15, 2019 /PRNewswire/ -- Below are experts from the ProfNet network who are available to discuss timely issues in your coverage area.

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019

Cavalier Logistics Continued Expansion

STERLING, Va., Feb. 15, 2019 /PRNewswire/ -- The year 2002 marked a strategic turning point for Cavalier Logistics. Their focus was set on the transportation and storage needs of the Temperature-Controlled Biopharma Market. Ever since, Cavalier Logistics has grown into one of the leading National... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Cavalier Logistics - Biopharma Healthcare Services Division

Clinical Data Presented from PIVOT-02 Study of Bempegaldesleukin (NKTR-214) with Nivolumab in Metastatic Urothelial Carcinoma Patients at the 2019 ASCO Genitourinary Cancers Symposium

SAN FRANCISCO, Feb. 15, 2019 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today a presentation of new clinical data for bempegaldesleukin(1) (NKTR-214) in combination with nivolumab in patients with first-line (1L) advanced or metastatic urothelial carcinoma at the 2019 American... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Nektar Therapeutics Inc

SHAREHOLDER ALERT: WeissLaw LLP Investigates CAS Medical Systems, Inc.

NEW YORK, Feb. 15, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  CAS Medical Systems, Inc.

CAS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CAS Medical Systems, Inc. - CASM

NEW ORLEANS, Feb. 15, 2019 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of CAS Medical Systems, Inc. (NasdaqCM: CASM) ("CASMed") to Edwards Lifesciences Corporation (NYSE:... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Edwards Lifesciences Corp. | CAS Medical Systems, Inc.

Suicide Prevention Advocates Storm the Capitol in Salt Lake

SALT LAKE CITY, Feb. 15, 2019 /PRNewswire/ -- Suicide is the tenth leading cause of death in the United States, and it is the seventh leading cause of death in Utah. On Tuesday, February 19, advocates from the Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019

American Regent Re-introduces Droperidol Injection, USP; AP Rated and Therapeutically Equivalent to InapsineĀ®1*

SHIRLEY, N.Y., Feb. 15, 2019 /PRNewswire/ -- American Regent, Inc. today announced the re-introduction of Droperidol Injection, USP.

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  American Regent, Inc.

BD to Present at Leerink Partners 8th Annual Global Healthcare Conference

FRANKLIN LAKES, N.J., Feb. 15, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at Leerink Partners 8(th) Annual Global Healthcare Conference on Thursday, February 28, 2019, at 10:00 a.m. ET.

... Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Becton, Dickinson and Company (BD)

Marker Therapeutics Announces Change in Corporate Headquarters and Access to New Laboratory Facility

HOUSTON, Feb. 15, 2019 /PRNewswire/ -- Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Marker Therapeutics, Inc

New Study Confirms Multiple Sclerosis Prevalence in the US is Nearly 1 Million People; More Than Twice As Many As Previous Number

NEW YORK, Feb. 15, 2019 /PRNewswire/ -- A study conducted by the National Multiple Sclerosis Society and... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Accelerated Cure Project for Multiple Sclerosis | National Multiple Sclerosis Society

U.S. and EU Patent Office Decisions Invalidate Amgen Subsidiary Immunex's Patents Claiming Antibodies to the IL-4 Receptor

TARRYTOWN, N.Y., Feb. 15, 2019 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Regeneron Pharmaceuticals, Inc.

Joerns Healthcare Announces Kevin Conway As Chief Commercial Officer

CHARLOTTE, N.C., Feb. 15, 2019 /PRNewswire/ -- Joerns Healthcare has announced that Kevin Conway has been selected to serve as the Company's Chief Commercial Officer.

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2019

Bausch Health Provides Update For DUOBRII Filing

LAVAL, Quebec, Feb. 15, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, announced that the U.S. Food and Drug Administration (FDA) will be unable to meet today's... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2019
Related companies:  Bausch Health Companies Inc.

Achaogen Announces Pricing of $15 Million Underwritten Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2019
Related companies:  Achaogen, Inc.

Cerecor Announces CERC-301 Granted U.S. Patent

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2019
Related companies:  Cerecor Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑